Local cytokine levels associated with delayed-type hypersensitivity responses: modulation by gender, ovariectomy, and estrogen replacement.
It is well established that females mount stronger immune responses than males, but only very little is understood about the underlying mechanisms. We have analyzed local cytokine differences among intact females, those that had been ovariectomized (OVX), those receiving estrogen replacement after OVX, and males, both before and after production of delayed-type hypersensitivity (DTH) responses. We report confirmation of a much larger DTH response in females versus males. However, OVX resulted in an even larger response, while estrogen replacement resulted in a smaller response when compared with intact females. In animals exposed for the first time to an antigen (without a DTH response), OVX increased interleukin-6 (IL-6) and estrogen replacement after OVX suppressed IL-6. Of the cytokines that differed between males and females exposed for the first time to an antigen, only IL-6 was higher in females versus males when exposure to antigen occurred for the second time (when the DTH response occurs). Analysis of cytokines with OVX and estrogen replacement after a second exposure to antigen showed that IL-6 did not significantly change. Levels of IL-4; Regulated upon Activation, Normal T-cell Expressed; and Secreted; and thrombopoietin, however, correlated with the DTH response, suggesting direct or indirect positive regulation by estrogen. These results suggest an important role for both IL-6 and IL-4 in determining the degree of DTH response, with IL-6 (which appears negatively regulated by estrogen) increasing and IL-4 (which appears positively regulated by estrogen) decreasing the response. The results further suggest that IL-6 may play a role in predisposing to a larger DTH response, while IL-4 levels seem more important during an active response.
Ma
Lisa J
LJ
Division of Biomedical Sciences, The University of California, Riverside, CA 92521, USA. lma003@student.ucr.edu
Guzmán
Esther A
EA
DeGuzman
Ariel
A
Muller
H Konrad
HK
Walker
Ameae M
AM
Owen
Laurie B
LB
D000818:Animals; D000941:Antigens / Q000494:pharmacology; D018946:Chemokine CCL5 / Q000097:blood; D016207:Cytokines / Q000097:blood*; D015914:Estrogen Replacement Therapy; D005260:Female; D005783:Gender Identity; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D015847:Interleukin-4 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010052:Ovariectomy; D013926:Thrombopoietin / Q000097:blood; D013997:Time Factors
D000941:Antigens; D018946:Chemokine CCL5; D016207:Cytokines; D015850:Interleukin-6; D015847:Interleukin-4; D013926:Thrombopoietin